N-Methyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 25g

5,7-dimethyl[1,2,4]triazolo[4,3-a]pyrimidine-3-thiol, 10g

3-(Methylaminomethyl)pyridine>98.0%(GC)(T)5g

Methyl 2-acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 250mg

2,3-Difluoro-6-hydroxybenzoic acid, 98.0%, 100mg

4-CHLORO-5-FLUORO-7-AZA-2-OXINDOLE, 95.0%, 10g

2-Bromo-1-(3,4-difluorophenyl)ethanone, 98%, 1g

Dabigatran>95.0%(HPLC)500mg

Nonafluoro-1-butanesulfonic Acid>98.0%(T)25g

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, 99%, 250mg

3-(2-Furyl)Acrylaldehyde, 98%, 5g

Standard for Total Base Number (TBN), ROTI®Calipure 10 mg KOH/g, 50 g, glass packaging

2-BROMO-5-FLUORO-4-NITROPHENOL, 95%, 100mg